Nikhil Khushalani, MD

Articles

Dr Khushalani on Fixed-Dose Treatment Regimens in Advanced Melanoma

July 2nd 2024

Nikhil Khushalani, MD, discusses the benefits and limitations of fixed-dose treatment regimens in patients with unresectable or metastatic melanoma.

Closing Thoughts on Intralesional Therapy for Melanoma and CSCC

May 24th 2023

A panel of skin cancer experts offer closing thoughts on intralesional therapy for treating melanoma and CSCC.

Tumor-Directed Oncolytic Therapies for Melanoma and CSCC

May 17th 2023

An expert panel discusses the use of tumor-directed oncolytic therapies for melanoma and cutaneous squamous cell carcinoma.

Treating Patients with High-Risk Melanoma

May 17th 2023

A comprehensive overview of treatment approaches for patients with high-risk melanoma.

Meaningful End Points for Patients with Metastatic Melanoma

May 10th 2023

Experts on skin cancer discuss valuable end points for determining successful treatments for patients with metastatic melanoma.

Deciding Between Melanoma Therapy Options

May 10th 2023

A panel of skin cancer experts share their thoughts on treatment selection for patients with melanoma.

BRAF/MEK Dual Inhibitors for Melanoma

May 3rd 2023

An expert panel analyzes BRAF/MEK dual inhibitor therapy for the treatment of melanoma.

Factors that Impact Treatment Selection for Melanoma

May 3rd 2023

Anna C. Pavlick, DO, discusses factors that impact treatment selection for patients with melanoma.

Future Treatment Landscape for Squamous Cell Carcinoma

April 26th 2023

Expert oncologists look to the future of treatment for cutaneous squamous cell carcinoma.

Treatment Duration Considerations for CSCC

April 26th 2023

Skin cancer expert Anna C. Pavlick, DO, discusses treatment duration approaches for cutaneous squamous cell carcinoma.

CSCC Treatment Options: Cemiplimab and Pembrolizumab

April 19th 2023

Nikhil Khushalani, MD, gives a comprehensive overview of cemiplimab and pembrolizumab for treating CSCC.

Choosing Systemic Therapies for Patients with Unresectable or Metastatic CSCC

April 19th 2023

Anna C. Pavlick, DO, overviews systemic therapy options for patients with unresectable or metastatic CSCC.

Multidisciplinary Management of CSCC

April 12th 2023

Nikhil Khushalani, MD, discusses the multidisciplinary team approach to treating patients with cutaneous squamous cell carcinoma.

Unmet Needs and Prognosis for CSCC and Melanoma

April 12th 2023

Skin cancer experts discuss prognosis and unmet needs in the cutaneous squamous cell carcinoma and melanoma treatment spaces.

Overview of Cutaneous Squamous Cell Carcinoma and Melanoma

March 31st 2023

A panel of skin cancer experts give an overview of cutaneous squamous cell carcinoma and melanoma.

Available Staging Systems for Cutaneous Squamous Cell Carcinoma

March 15th 2023

A review of current staging systems used to categorize CSCC, particularly those from the American Joint Committee on Cancer and Brigham and Women's Hospital.

Cutaneous Squamous Cell Carcinoma: Incidence and Risk Factors

March 15th 2023

Opening their discussion on resectable cutaneous squamous cell carcinoma (CSCC), expert panelists elucidate its current incidence and known risk factors.

Looking Ahead: Unmet Needs for the Treatment of BCC

November 9th 2022

Nikhil Khushalani, MD, comments on upcoming treatment advances he looks forward to for patients with BCC.

Treatment Options for Patients with Advanced Basal Cell Carcinoma (BCC)

November 2nd 2022

An expert provides a brief overview of basal cell carcinoma (BCC) and reviews currently available treatment options for patients with BCC.

Future Perspectives in cSCC

November 2nd 2022

Dr Khushalani discusses challenges faced when treating patients with cSCC and shares advice for fellow colleagues who treat patients with cSCC.